Sign in

NCT07008027Not yet recruiting

Real World Asparaginase Therapy Toxicity

Source: ClinicalTrials.gov · Last updated 22 Oct 2026

Brief summary (registry, in English)

This research study is being done to learn more about the short term and long term side effects of treatment with asparaginase drugs, which are commonly used in acute lymphoblastic leukemia (ALL) or acute lymphoblastic lymphoma (LLy) therapy.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
28 May 2025
Start date
Nov 2026
Primary completion date
Jul 2030
Lead sponsor
St. Jude Children's Research Hospital
NCT number
NCT07008027

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From Nov 2026 to the primary completion date, Jul 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Inability or unwillingness of research participant or legal guardian/representative to give written informed consent.

Who the study is looking for

  • Diagnosis of acute lymphoblastic leukemia, lymphoblastic lymphoma, or mixed phenotype acute leukemia
  • Enrolled on INITIALL and no more than 10 days after initiation of post-INITIALL therapy
  • Post-INITIALL therapy is:
    • Standard of Care (SOC)/Non Protocol Treatment Plan (NPTP) as per Total therapy or
    • SJALL23T and not scheduled to receive venetoclax

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
St. Jude Children's Research Hospital
Coordinator of this site? Confirm its status		MemphisUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.